Cristiana Barbati, Cristiano Alessandri, Marta Vomero, Rosa Vona, Tania Colasanti, Davide Vacirca, Serena Camerini, Marco Crescenzi, Monica Pendolino, Simona Truglia, Fabrizio Conti, Tina Garofalo, Maurizio Sorice, Marina Pierdominici, Guido Valesini, Walter Malorni, Elena Ortona
文献索引：J. Autoimmun. 58 , 78-89, (2015)
全文：HTML全文
T lymphocytes from patients with Systemic Lupus Erythematosus (SLE) display multiple abnormalities, including increased cell activation, abnormal cell death by apoptosis and impairment of autophagy pathway. In the present study we report the presence of specific antibodies to D4GDI, a small GTPase family inhibitor, in a significant percentage (46%) of SLE patient sera. We also found a significant association between the presence of these autoantibodies and hematologic manifestations occurring in these patients. Investigating the possible implication of anti-D4GDI autoantibodies in SLE pathogenesis or progression, we found that these antibodies were capable of binding D4GDI expressed at the lymphocyte surface and triggering a series of subcellular events, including Rho GTPase activation. These antibodies were also able to induce autophagy in T cells from both healthy donors and SLE patients, but only those negative to these antibodies. We can conclude that anti-D4GDI autoantibodies could be capable of triggering important responses in T cells such as cytoskeleton remodeling and autophagy pathway and that, in SLE patients, the chronic exposure to these specific autoantibodies could lead to the selection of autophagy-resistant T cell clones contributing to the pathogenesis of the disease. Copyright © 2015 Elsevier Ltd. All rights reserved.
